Cell-free DNA analyses were accurate in detecting fetal antigen status as early as 10 weeks’ gestation in women with alloimmunized pregnancies, according to results of a large, diverse U.S ...

Two professional societies have released comments on the use of cell-free fetal (cff) DNA noninvasive prenatal testing (NIPT) to detect trisomies in low-risk pregnant women. The statements follow ...

The global Cell-free fetal DNA testing market is estimated to be valued at USD 1,687.8 million in 2025 and is projected to reach USD 3,051.5 million by 2035, registering a compound annual growth rate ...

Non-invasive prenatal testing (NIPT), also known as prenatal-cell-free DNA-screening, allows a pregnant individual to receive a blood test that screens for very large changes in fetal chromosomes ...

Several physicians' organizations have supported use of the newer cell free fetal DNA tests over the standard screening in older, high-risk women.

Lo, professor of chemical pathology at the Chinese University of Hong Kong (CUHK), had discovered that fetal DNA makes up about 5% of the cell-free DNA in maternal plasma. In contrast, fetal cells are ...

Cell-free DNA testing uses a small amount of a person's blood and tests it for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in theory ...

CHICAGO — A cell-free DNA blood-based test displayed 83% sensitivity for colorectal cancer detection and 90% specificity in an average-risk population, similar to the performance of current ...

Further testing, however, showed that some 2.7 percent of fetuses had chromosomal defects, including those that could not have been detected by the new fetal DNA technique.